CIK 0000313143
- Large accelerated filer
HAEMONETICS CORP
Sign in to watch- Ticker
- HAE
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Apr 3
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 042882273
- Phone
- +1 781-848-7100
- Business address
- 125 SUMMER STREET, BOSTON, MA, 02110
- 4 Open-market sale CFO & EVP Business Development sold 436 shares at $32.13 ($14,008)
- 4 Open-market sale Chief Operating Officer sold 278 shares at $31.75 ($8,826)
- 4 Open-market sale President, Global Markets sold 191 shares at $31.75 ($6,064)
- 4 Open-market sale EVP and Chief Legal Officer sold 250 shares at $31.75 ($7,937)
- 4 Open-market sale Chief Science and Technology sold 250 shares at $31.75 ($7,937)
- 4 Open-market sale VP Finance sold 162 shares at $31.75 ($5,143)
- 4 Open-market sale EVP, Global QA/RA sold 249 shares at $31.75 ($7,906)
- 4 Grant or award EVP, Global QA/RA acquired 3,909 shares (grant or award)
- 4 Grant or award EVP, Global Human Resources acquired 2,736 shares (grant or award)
- 4 Grant or award EVP and Chief Legal Officer acquired 3,323 shares (grant or award)
- 4 Grant or award CFO & EVP Business Development acquired 6,255 shares (grant or award)
- 4 Grant or award President, Global Markets acquired 3,909 shares (grant or award)
- 4 Grant or award Chief Science and Technology acquired 4,105 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 9,774 shares (grant or award)
- 4 Grant or award EVP, Global Manufacturing acquired 4,222 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President & CEO sold 6,569 shares at $35.15 ($230,900)
- 4 Open-market sale President & CEO sold 4,765 shares at $35.63 ($169,792)
- 4 Open-market sale CFO & EVP Business Development sold 4,902 shares at $38.49 ($188,688)
- 4 Open-market sale President & CEO sold 6,569 shares at $39.28 ($258,019)
Page 23 of 60 · 1,191 filings